These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 28374768

  • 1. Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography.
    Lemoine L, Saint-Aubert L, Nennesmo I, Gillberg PG, Nordberg A.
    Sci Rep; 2017 Apr 04; 7():45496. PubMed ID: 28374768
    [Abstract] [Full Text] [Related]

  • 2. Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue.
    Lemoine L, Saint-Aubert L, Marutle A, Antoni G, Eriksson JP, Ghetti B, Okamura N, Nennesmo I, Gillberg PG, Nordberg A.
    Acta Neuropathol Commun; 2015 Jul 02; 3():40. PubMed ID: 26134112
    [Abstract] [Full Text] [Related]

  • 3. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.
    Lemoine L, Gillberg PG, Svedberg M, Stepanov V, Jia Z, Huang J, Nag S, Tian H, Ghetti B, Okamura N, Higuchi M, Halldin C, Nordberg A.
    Alzheimers Res Ther; 2017 Dec 11; 9(1):96. PubMed ID: 29229003
    [Abstract] [Full Text] [Related]

  • 4. Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.
    Lemoine L, Ledreux A, Mufson EJ, Perez SE, Simic G, Doran E, Lott I, Carroll S, Bharani K, Thomas S, Gilmore A, Hamlett ED, Nordberg A, Granholm AC.
    Mol Neurodegener; 2020 Nov 23; 15(1):68. PubMed ID: 33222700
    [Abstract] [Full Text] [Related]

  • 5. ³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain.
    Marutle A, Gillberg PG, Bergfors A, Yu W, Ni R, Nennesmo I, Voytenko L, Nordberg A.
    J Neuroinflammation; 2013 Jul 23; 10():90. PubMed ID: 23880036
    [Abstract] [Full Text] [Related]

  • 6. Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9.
    Lemoine L, Gillberg PG, Bogdanovic N, Nennesmo I, Saint-Aubert L, Viitanen M, Graff C, Ingelsson M, Nordberg A.
    Mol Psychiatry; 2021 Oct 23; 26(10):5609-5619. PubMed ID: 32581318
    [Abstract] [Full Text] [Related]

  • 7. Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models.
    Brendel M, Jaworska A, Probst F, Overhoff F, Korzhova V, Lindner S, Carlsen J, Bartenstein P, Harada R, Kudo Y, Haass C, Van Leuven F, Okamura N, Herms J, Rominger A.
    J Nucl Med; 2016 May 23; 57(5):792-8. PubMed ID: 26912432
    [Abstract] [Full Text] [Related]

  • 8. Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases.
    Malarte ML, Nordberg A, Lemoine L.
    Eur J Nucl Med Mol Imaging; 2021 Apr 23; 48(4):1093-1102. PubMed ID: 32970217
    [Abstract] [Full Text] [Related]

  • 9. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.
    Gulyás B, Pavlova E, Kása P, Gulya K, Bakota L, Várszegi S, Keller E, Horváth MC, Nag S, Hermecz I, Magyar K, Halldin C.
    Neurochem Int; 2011 Jan 23; 58(1):60-8. PubMed ID: 21075154
    [Abstract] [Full Text] [Related]

  • 10. Hyperphosphorylated tau in Alzheimer's disease disseminates along pathways predicted by the Structural Model for Cortico-cortical Connections.
    Uceda-Heras A, Aparicio-Rodríguez G, García-Cabezas MÁ.
    J Comp Neurol; 2024 May 23; 532(5):e25623. PubMed ID: 38803103
    [Abstract] [Full Text] [Related]

  • 11. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.
    Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, Tago T, Hiraoka K, Watanuki S, Shidahara M, Miyake M, Ishikawa Y, Matsuda R, Inami A, Yoshikawa T, Funaki Y, Iwata R, Tashiro M, Yanai K, Arai H, Kudo Y.
    J Nucl Med; 2016 Feb 23; 57(2):208-14. PubMed ID: 26541774
    [Abstract] [Full Text] [Related]

  • 12. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
    Okamura N, Furumoto S, Harada R, Tago T, Yoshikawa T, Fodero-Tavoletti M, Mulligan RS, Villemagne VL, Akatsu H, Yamamoto T, Arai H, Iwata R, Yanai K, Kudo Y.
    J Nucl Med; 2013 Aug 23; 54(8):1420-7. PubMed ID: 23857514
    [Abstract] [Full Text] [Related]

  • 13. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K, Uemura K, Asada M, Maesako M, Akiyama H, Shimohama S, Takahashi R, Kinoshita A.
    Mol Brain; 2015 Dec 04; 8(1):82. PubMed ID: 26637371
    [Abstract] [Full Text] [Related]

  • 14. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA, Nafe R, Schlote W.
    Brain Res; 2008 Jun 05; 1213():152-65. PubMed ID: 18455153
    [Abstract] [Full Text] [Related]

  • 15. Development and evaluation of [125 I]IPPI for Tau imaging in postmortem human Alzheimer's disease brain.
    Mukherjee J, Liang C, Patel KK, Lam PQ, Mondal R.
    Synapse; 2021 Jan 05; 75(1):e22183. PubMed ID: 32722889
    [Abstract] [Full Text] [Related]

  • 16. Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease.
    Li Y, Tsui W, Rusinek H, Butler T, Mosconi L, Pirraglia E, Mozley D, Vallabhajosula S, Harada R, Furumoto S, Furukawa K, Arai H, Kudo Y, Okamura N, de Leon MJ.
    J Nucl Med; 2015 Feb 05; 56(2):270-3. PubMed ID: 25572087
    [Abstract] [Full Text] [Related]

  • 17. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M, Wall A, Chiotis K, Saint-Aubert L, Wilking H, Sprycha M, Borg B, Thibblin A, Eriksson J, Sörensen J, Antoni G, Nordberg A, Lubberink M.
    J Nucl Med; 2016 Apr 05; 57(4):574-81. PubMed ID: 26795290
    [Abstract] [Full Text] [Related]

  • 18. Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain.
    Ng KP, Pascoal TA, Mathotaarachchi S, Therriault J, Kang MS, Shin M, Guiot MC, Guo Q, Harada R, Comley RA, Massarweh G, Soucy JP, Okamura N, Gauthier S, Rosa-Neto P.
    Alzheimers Res Ther; 2017 Mar 31; 9(1):25. PubMed ID: 28359327
    [Abstract] [Full Text] [Related]

  • 19. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
    van de Nes JA, Konermann S, Nafe R, Swaab DF.
    Acta Neuropathol; 2006 Feb 31; 111(2):126-38. PubMed ID: 16456666
    [Abstract] [Full Text] [Related]

  • 20. In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.
    Kikuchi A, Okamura N, Hasegawa T, Harada R, Watanuki S, Funaki Y, Hiraoka K, Baba T, Sugeno N, Oshima R, Yoshida S, Kobayashi J, Ezura M, Kobayashi M, Tano O, Mugikura S, Iwata R, Ishiki A, Furukawa K, Arai H, Furumoto S, Tashiro M, Yanai K, Kudo Y, Takeda A, Aoki M.
    Neurology; 2016 Nov 29; 87(22):2309-2316. PubMed ID: 27794115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.